James Andrew Reeves
James Andrew Reeves publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, on topics such as Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment and Cancer Treatment and Pharmacology.
- World rank
- #650,543 of 7,710,434 ranked researchers
- Rank in United States
- #221,533 of 1,627,098
- Works
- 83
- Citations
- 8.1k
- Citations per work
- 97.5
What does James Andrew Reeves research?
James Andrew Reeves's work is mostly in Medicine (56%), Biochemistry, Genetics and Molecular Biology (19%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences4655.8%
- Medicine4655.8%
- Everything else2124.8%
- Life Sciences1619.4%
- 1Oncology25% of their works
- 2Pulmonary and Respiratory Medicine12% of their works
- 3Molecular Biology12% of their works
- 4Pathology and Forensic Medicine10% of their works
- 5Genetics9% of their works
- 6Cancer Research7% of their works
Research topics
Which keywords describe James Andrew Reeves's research?
The keywords of their largest research topics: Rituximab, Prognostic Factors, Chronic Lymphocytic Leukemia, Classification, Genomic Aberrations, Lymphoma, Chemotherapy-Induced Peripheral Neuropathy and Taxanes.
- mTOR
- PD-1 and PD-L1
- International Myeloma Working Group
- Renal Cell Carcinoma
- Mutational Signatures
- Taxanes
- Lymphoma
- Classification
- Prognostic Factors
- Rituximab
- Chronic Lymphocytic Leukemia
- Genomic Aberrations
- Chemotherapy-Induced Peripheral Neuropathy
- Cancer Genomics
- Metastatic
- Diagnosis Criteria
- Immune Checkpoint Blockade
- Signaling
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Rituximab382 topics
- Prognostic Factors312 topics
- Chronic Lymphocytic Leukemia191 topic
- Classification191 topic
- Genomic Aberrations191 topic
- Lymphoma191 topic
- Chemotherapy-Induced Peripheral Neuropathy141 topic
- Taxanes141 topic
- Cancer Genomics131 topic
- Mutational Signatures131 topic
- Metastatic121 topic
- Renal Cell Carcinoma121 topic
- Diagnosis Criteria91 topic
- International Myeloma Working Group91 topic
- Immune Checkpoint Blockade81 topic
- PD-1 and PD-L181 topic
- Signaling81 topic
- mTOR81 topic
Where does James Andrew Reeves work?
James Andrew Reeves's main affiliation in the publication record is Sarah Cannon, United States.
How many publications and citations does James Andrew Reeves have?
OpenAlex counts 83 works and 8,095 citations for James Andrew Reeves, an h-index of 26, ranking #650,543 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about James Andrew Reeves. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.